Bigul

JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Recommendations of the Committee of Independent Directors ('IDC') of Jagsonpal Pharmaceuticals Limited ('Target Company') on the Open Offer (as defined below) made by Infinity Holdings ('Acquirer'), together with Infinity Holdings Sidecar I ('PAC 1') and Infinity Consumer Holdings ('PAC 2'), in their capacity as persons acting in concert with the Acquirer (collectively, 'PACs'), to the public shareholders of the Target Company, under Regulation 26(7) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 and subsequent amendments thereto ('SEBI (SAST) Regulations').
06-06-2022
Bigul

JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Updates on Open Offer

Centrum Capital Ltd ("Manager to the Offer") has submitted to BSE a copy of Pre-Offer Advertisement in accordance with Regulation 18(7) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, as amended, and Corrigendum to the Detailed Public Statement with respect to the Open Offer to the eligible public shareholders of Jagsonpal Pharmaceuticals Ltd ("Target Company").
06-06-2022
Bigul

JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Updates on Open Offer (Recommendation of the Committee of Independent Directors ('IDC')

Centrum Capital Ltd ("Manager to the Offer") has submitted to BSE a copy of Recommendation of the Committee of Independent Directors ('IDC') on the Open Offer' to the public shareholders of Jagsonpal Pharmaceuticals Ltd ("Target Company") as publised in the newspapers in terms of Regulation 26(7) of the SEBI (SAST) Regulations, 2011.
03-06-2022
Bigul

JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Letter of Offer

Centrum Capital Ltd ("Manager to the Offer") has submitted to BSE a copy of Letter of Offer to the eligible public shareholders of Jagsonpal Pharmaceuticals Ltd ("Target Company").
31-05-2022
Bigul

JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Audited Financial Results For The Quarter And Financial Year Ended 31 March, 2022.

Audited Financial Results for the quarter and financial year ended 31 March, 2022.
30-05-2022
Bigul

JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Board Meeting Outcome for OUTCOME OF THE MEETING OF BOARD OF DIRECTORS OF JAGSONPAL PHARMACEUTICALS LIMITED HELD ON MAY 30TH, 2022

This is to intimate that the Board of Directors of the Company at their meeting held today, (i.e. Monday, the 30th Day of May, 2022), commenced at 1200 hours and concluded on 1755 hours at registered office, have inter alia, approved and taken on record the following: 1. Pursuant to Regulation 33 of the SEBI (Listing Obligation & Disclosure Requirements) Regulations, 2015, Audited Standalone Financial Results of the Company for the Quarter and financial year ended 31st March, 2022; 2. Audit Report for the Quarter and financial year ended 31st March, 2022; 3. Approved the Directors' Report together with Management Discussion and Analysis Report along with Report on Corporate Governance; 4. Other Agenda items. Further, we declare that the Report of Auditors are with unmodified opinion with respect to the Audited Financial Results of the Company for the quarter and financial year ended March 31, 2022. Kindly take the above on record & oblige.
30-05-2022
Bigul

JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Board Meeting Intimation for For Audited Financial Results For The Quarter And Financial Year Ended March 31, 2022.

JAGSONPAL PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2022 ,inter alia, to consider and approve The Standalone Audited Financial Results of the Company for the quarter and year ended 31st March, 2022.
22-05-2022
Bigul

JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Book Closure For The Purpose Of EGM

Book Closure for the purpose of EGM: From Friday, June 10, 2022 to Friday, June 17, 2022.
20-05-2022
Next Page
Close

Let's Open Free Demat Account